Kim Mulholland

19.3k total citations · 1 hit paper
279 papers, 10.1k citations indexed

About

Kim Mulholland is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Kim Mulholland has authored 279 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Epidemiology, 70 papers in Microbiology and 39 papers in Infectious Diseases. Recurrent topics in Kim Mulholland's work include Pneumonia and Respiratory Infections (157 papers), Respiratory viral infections research (103 papers) and Bacterial Infections and Vaccines (69 papers). Kim Mulholland is often cited by papers focused on Pneumonia and Respiratory Infections (157 papers), Respiratory viral infections research (103 papers) and Bacterial Infections and Vaccines (69 papers). Kim Mulholland collaborates with scholars based in United Kingdom, Australia and United States. Kim Mulholland's co-authors include Katherine L. O’Brien, Thomas Cherian, Orin S. Levine, Emily Henkle, Maria Deloria Knoll, Ellen Lee, Natalie McCall, Lara J. Wolfson, James Watt and Fiona M. Russell and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Kim Mulholland

269 papers receiving 9.8k citations

Hit Papers

Burden of disease caused by Streptococcus pneumoniae in c... 2009 2026 2014 2020 2009 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Mulholland United Kingdom 49 6.6k 2.7k 1.5k 1.3k 947 279 10.1k
Orin S. Levine United States 48 5.9k 0.9× 2.5k 0.9× 1.2k 0.8× 1.2k 0.9× 509 0.5× 116 8.3k
J. Anthony G. Scott United Kingdom 47 4.2k 0.6× 1.1k 0.4× 1.2k 0.8× 1.2k 0.9× 430 0.5× 160 7.5k
Katherine L. O’Brien United States 66 13.5k 2.0× 4.6k 1.7× 2.9k 1.9× 2.8k 2.1× 1.3k 1.3× 257 19.2k
Shamez Ladhani United Kingdom 61 7.3k 1.1× 4.4k 1.6× 3.6k 2.3× 2.2k 1.7× 944 1.0× 382 14.4k
Flor M. Muñoz United States 44 3.8k 0.6× 1.2k 0.5× 1.7k 1.1× 614 0.5× 621 0.7× 205 6.8k
Thomas M. Lietman United States 51 2.7k 0.4× 2.0k 0.7× 1.4k 0.9× 2.3k 1.7× 431 0.5× 389 10.8k
Elizabeth R. Zell United States 48 7.0k 1.1× 2.8k 1.0× 1.8k 1.2× 2.6k 1.9× 514 0.5× 128 10.4k
Mathuram Santosham United States 65 5.8k 0.9× 2.1k 0.8× 3.2k 2.1× 1.1k 0.9× 1.1k 1.1× 284 13.7k
Geraldine M. McQuillan United States 51 11.4k 1.7× 1.8k 0.7× 2.5k 1.7× 1.3k 1.0× 434 0.5× 92 17.7k
Hope L. Johnson United States 21 3.0k 0.5× 833 0.3× 1.3k 0.9× 1.1k 0.8× 762 0.8× 39 7.6k

Countries citing papers authored by Kim Mulholland

Since Specialization
Citations

This map shows the geographic impact of Kim Mulholland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Mulholland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Mulholland more than expected).

Fields of papers citing papers by Kim Mulholland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Mulholland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Mulholland. The network helps show where Kim Mulholland may publish in the future.

Co-authorship network of co-authors of Kim Mulholland

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Mulholland. A scholar is included among the top collaborators of Kim Mulholland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Mulholland. Kim Mulholland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, J. L., Fiona M. Russell, Rita Reyburn, et al.. (2025). Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine. Nature Communications. 16(1). 2130–2130.
2.
Mollendorf, Claire von, et al.. (2025). Measles Seroprevalence in Infants Under 9 Months of Age in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. 232(2). 316–326. 1 indexed citations
3.
Tsedenbal, Naranzul, Casey L. Pell, Sam Manna, et al.. (2024). Respiratory Syncytial Virus and Influenza Infections in Children in Ulaanbaatar, Mongolia, 2015–2021. Influenza and Other Respiratory Viruses. 18(5). e13303–e13303. 5 indexed citations
4.
Manna, Sam, Eileen M. Dunne, Casey L. Pell, et al.. (2024). Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice. Vaccine. 42(7). 1714–1722. 1 indexed citations
5.
Campo, John de, Margaret de Campo, Eileen M. Dunne, et al.. (2023). Impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia hospitalisations in Mongolia: a time series analysis. The Lancet Regional Health - Western Pacific. 44. 100983–100983.
6.
Feng, Shuo, Julie McLellan, Nia Roberts, et al.. (2023). Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data. EClinicalMedicine. 61. 102073–102073. 5 indexed citations
7.
Feng, Shuo, Julie McLellan, Nia Roberts, et al.. (2023). Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health Technology Assessment. 28(34). 1–109.
8.
Nation, Monica Larissa, Sam Manna, Cattram Nguyen, et al.. (2023). Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam. Microbiology Spectrum. 11(1). e0361522–e0361522. 19 indexed citations
9.
David, Shannon C., Erin B. Brazel, Hui Wang, et al.. (2022). A Nonadjuvanted Whole-Inactivated Pneumococcal Vaccine Induces Multiserotype Opsonophagocytic Responses Mediated by Noncapsule-Specific Antibodies. mBio. 13(5). e0236722–e0236722. 6 indexed citations
10.
Toh, Zheng Quan, et al.. (2021). Australia’s Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific. Vaccines. 9(8). 921–921. 1 indexed citations
11.
Chan, Jocelyn, Heather F. Gidding, Christopher C. Blyth, et al.. (2021). Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study. PLoS Medicine. 18(8). e1003733–e1003733. 5 indexed citations
12.
Knight, James, et al.. (2020). Determining the serotype composition of mixed samples of pneumococcus using whole-genome sequencing. Microbial Genomics. 7(1). 14 indexed citations
13.
Dunne, Eileen M., Katherine A. Gould, Jorge E. Vidal, et al.. (2020). The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults. mSphere. 5(4). 13 indexed citations
14.
Prasad, Namrata, Aaron Jenkins, Mike Kama, et al.. (2018). Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014–2017: A case-control study. PLoS neglected tropical diseases. 12(6). e0006571–e0006571. 29 indexed citations
15.
Balloch, Anne, Paul V. Licciardi, Andrew S. Kemp, et al.. (2014). Comparison of Anti-pneumococcal Antibodies in Cord Blood From Australian Indigenous and Gambian Neonates and the Implications for Otitis Media. The Pediatric Infectious Disease Journal. 33(4). e116–e120. 2 indexed citations
16.
Tikoduadua, Lisi, Kristy Azzopardi, Beth Temple, et al.. (2012). Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae. International Journal of Infectious Diseases. 16(4). e289–e295. 24 indexed citations
17.
Niessen, Louis, et al.. (2009). Comparative Impact Assessment of Child Pneumonia interventions/Evaluation Comparative Des Impacts Des Interventions Contre la Pneumonie Chez l'enfant/Evaluacion Comparativa del Impacto De Las Intervenciones Contra la Neumonia En la Ninez. Bulletin of the World Health Organization. 87(6). 472. 1 indexed citations
18.
Rudan, Igor, Cynthia Boschi-Pinto, Zrinka Biloglav, Kim Mulholland, & Harry Campbell. (2008). Epidemiología y etiología de la neumonía en la niñez. Bulletin of the World Health Organization. 86(5). 2 indexed citations
19.
Falade, Adegoke G., R. A. Adegbola, Kim Mulholland, & Brian Greenwood. (2001). Respiratory rate as a predictor of positive lung aspirates in young Gambian children with lobar pneumonia. Annals of Tropical Paediatrics. 21(4). 293–297. 3 indexed citations
20.
Mulholland, Kim, et al.. (1999). A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations.. PubMed. 3(9). 749–55. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026